Loading
Latest filing published 07 Dec 2015 for Midatech Pharma US Inc..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Haywood D. Cochrane is a declared insider at 2 companies; the most frequent names are Midatech Pharma US Inc. and I Trax Inc. Between 29 April 2008 and 4 December 2015, the trades on record add up to 10 filings.
Every open-market trade on record is a purchase: 5 purchases worth €14k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 3 share grants.
A typical purchase (the median) is worth €1,787.
On 7 December 2015 came the latest disclosure, a transaction in Midatech Pharma US Inc. The last purchase on record was published on 31 May 2013, which is 4,894 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations